Skip to main content
. 2021 Jun 4;16(6):e0252480. doi: 10.1371/journal.pone.0252480

Table 4. Association between peripheral ImmunoCRIT and tumor immune microenvironment in resected gastric cancer.

Peripheral ImmunoCRIT p-value
High Low
CD45RO, cells/mm2 Tumor central 126.8 (103.5) 125.5 (90.4) 0.901
Tumor peripheral 81.8 (77.3) 92.6 (82.6) 0.195
Arginase, pixel/mm2 Tumor central 139726.4 (721655.8) 112446.4 (204730.4) 0.631
Tumor peripheral 63056.7 (136848.4) 49222.6 (112344.7) 0.334
CD68, pixel/mm2 Tumor central 402842.4 (317123.3) 378560.9 (313045.1) 0.459
Tumor peripheral 271870.7 (235358.5) 298407.6 (260537.8) 0.301
CD163, pixel/mm2 Tumor central 156599.0 (212138.9) 164302.7 (189831.0) 0.714
Tumor peripheral 183522.1 (224505.5) 231384.1 (309892.7) 0.084
CD3, cells/mm2 Tumor central 201.2 (146.0) 172.2 (110.2) 0.029
Tumor peripheral 147.6 (132.8) 152.5 (132.0) 0.720
CD4, cells/mm2 Tumor central 56.5 (48.4) 43.5 (42.3) 0.007
Tumor peripheral 36.8 (38.4) 37.0 (33.9) 0.952
CD8, cells/mm2 Tumor central 140.5 (104.9) 136.2 (100.8) 0.686
Tumor peripheral 95.8 (83.3) 110.8 (87.2) 0.091
Foxp3, cells/mm2 Tumor central 136.8 (110.9) 146.9 (106.0) 0.369
Tumor peripheral 95.5 (113.5) 120.3 (136.4) 0.060

SD, Standard deviation. Data are presented as mean (standard deviation).